These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cost-effectiveness: a new criterion for selecting therapy. Jönsson B J Intern Med; 1995 Jan; 237(1):1-3. PubMed ID: 7830021 [No Abstract] [Full Text] [Related]
4. Is the experimental treatment exclusion used appropriately? Priester R Minn Med; 2000 Jan; 83(1):26-8. PubMed ID: 10680428 [No Abstract] [Full Text] [Related]
5. Unintended consequences of applying economic evaluation. Oliver A J Health Serv Res Policy; 2002 Jul; 7(3):129-30. PubMed ID: 12171741 [No Abstract] [Full Text] [Related]
6. Can we treat cancer for a dollar a day? Guidelines for low-income countries. Kerr DJ; Midgley R N Engl J Med; 2010 Aug; 363(9):801-3. PubMed ID: 20818843 [No Abstract] [Full Text] [Related]
8. New MRC guidance on evaluating complex interventions. Anderson R BMJ; 2008 Oct; 337():a1937. PubMed ID: 18945728 [No Abstract] [Full Text] [Related]
9. New treatments: costs, benefits and decision-making procedures. Benatar SR; Fleischer TE S Afr Med J; 2003 Jun; 93(6):433-4. PubMed ID: 12916379 [No Abstract] [Full Text] [Related]
10. Searching for El Dorado: the impossibility of finding the right rate. Frohlich N; Roos NP CMAJ; 2002 Oct; 167(8):880-1. PubMed ID: 12406947 [No Abstract] [Full Text] [Related]
11. A population approach to the rational use of therapeutic interventions. Rawlins MD Clin Ther; 2013 Oct; 35(10):1634-8. PubMed ID: 23998968 [No Abstract] [Full Text] [Related]
12. Survey of cost-effectiveness and cost-benefit analyses in industrialized countries. Drummond MF World Health Stat Q; 1985; 38(4):383-401. PubMed ID: 3938110 [No Abstract] [Full Text] [Related]
13. The economic value of companion diagnostics and stratified medicines. Blair ED; Stratton EK; Kaufmann M Expert Rev Mol Diagn; 2012 Nov; 12(8):791-4. PubMed ID: 23249194 [No Abstract] [Full Text] [Related]
14. [Should medical errors be avoided at any price?]. Kristiansen IS Tidsskr Nor Laegeforen; 2000 Oct; 120(26):3178-83. PubMed ID: 11109368 [No Abstract] [Full Text] [Related]
15. Cost effectiveness and the allocation of therapies in a treating population. Langley PC Pharmacoeconomics; 1996 Jul; 10(1):93-8. PubMed ID: 10160473 [TBL] [Abstract][Full Text] [Related]
16. Should case records report costs? Bader M N Engl J Med; 1984 Oct; 311(14):924. PubMed ID: 6472416 [No Abstract] [Full Text] [Related]
17. [Methods of comparative economic evaluations of therapies and for rational allocation of resources across sectors of health care systems - introduction, advantages, risks]. Wasem J; Hessel F; Kerim-Sade C Psychiatr Prax; 2001 Jul; 28 Suppl 1():S12-20. PubMed ID: 11533902 [TBL] [Abstract][Full Text] [Related]
18. Discussion: research and the cost of treatment. Ciba Found Symp; 1976; (44):89-95. PubMed ID: 1052070 [No Abstract] [Full Text] [Related]
19. Principles of cost effectiveness analysis for the assessment of current and new therapies. Hillner BE; Smith TJ; Desch CE J Hematother; 1993; 2(4):501-6. PubMed ID: 8087498 [TBL] [Abstract][Full Text] [Related]
20. Serving patient needs while implementing cost effectiveness programs in health care administration. Tootelian DH Health Mark Q; 1994; 11(3-4):161-73. PubMed ID: 10137013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]